Genprex, Inc. (GNPX) NASDAQ

0.21

-0.0178(-7.76%)

Updated at September 08 03:10PM

Currency In USD

Genprex, Inc.

Address

3300 Bee Cave Road

Austin, TX 78746

United States of America

Phone

877 774 4679

Sector

Healthcare

Industry

Biotechnology

Employees

15

First IPO Date

March 29, 2018

Key Executives

NameTitlePayYear Born
Mr. Ryan M. Confer M.S.President, Chief Executive Officer, Chief Financial Officer & Director509,8421982
Dr. Mark S. Berger M.D.Chief Medical Officer532,0051955
Mr. David M. SchlossSenior Vice President of Human Resources0N/A
Dr. Jack A. Roth F.A.C.S., M.D.Chairman of Scientific & Medical Advisory Board0N/A
Dr. Suzanne Thornton-Jones Ph.D.Senior Vice President of Regulatory Affairs & Quality0N/A
Mr. Thomas C. Gallagher Esq.Senior Vice President of Intellectual Property & Licensing0N/A

Description

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.